Alpha Tau Medical Ltd. (DRTS)

Alpha Tau Medical Statistics

Total Valuation

DRTS has a market cap or net worth of $313.81 million. The enterprise value is $239.77 million.

Market Cap	313.81M
Enterprise Value	239.77M

Important Dates

The last earnings date was Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

DRTS has 85.04 million shares outstanding. The number of shares has increased by 4.48% in one year.

Current Share Class	85.04M
Shares Outstanding	85.04M
Shares Change (YoY)	+4.48%
Shares Change (QoQ)	+14.20%
Owned by Insiders (%)	16.16%
Owned by Institutions (%)	1.87%
Float	57.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.53
P/TBV Ratio	3.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.52, with a Debt / Equity ratio of 0.15.

Current Ratio	10.52
Quick Ratio	9.77
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-121.82

Financial Efficiency

Return on equity (ROE) is -43.83% and return on invested capital (ROIC) is -25.15%.

Return on Equity (ROE)	-43.83%
Return on Assets (ROA)	-22.66%
Return on Invested Capital (ROIC)	-25.15%
Return on Capital Employed (ROCE)	-36.50%
Revenue Per Employee	n/a
Profits Per Employee	-$281,640
Employee Count	125
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DRTS has paid $166,000 in taxes.

Income Tax	166,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.90% in the last 52 weeks. The beta is 1.01, so DRTS's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	+57.90%
50-Day Moving Average	3.18
200-Day Moving Average	3.01
Relative Strength Index (RSI)	65.16
Average Volume (20 Days)	66,951

Short Selling Information

The latest short interest is 77,343, so 0.09% of the outstanding shares have been sold short.

Short Interest	77,343
Short Previous Month	74,385
Short % of Shares Out	0.09%
Short % of Float	0.14%
Short Ratio (days to cover)	1.46

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-37.52M
Pretax Income	-29.14M
Net Income	-35.21M
EBITDA	-36.45M
EBIT	-37.52M
Earnings Per Share (EPS)	-$0.48

Balance Sheet

The company has $79.70 million in cash and $13.31 million in debt, giving a net cash position of $66.39 million or $0.78 per share.

Cash & Cash Equivalents	79.70M
Total Debt	13.31M
Net Cash	66.39M
Net Cash Per Share	$0.78
Equity (Book Value)	86.62M
Book Value Per Share	1.02
Working Capital	77.62M

Cash Flow

In the last 12 months, operating cash flow was -$21.59 million and capital expenditures -$5.33 million, giving a free cash flow of -$26.92 million.

Operating Cash Flow	-21.59M
Capital Expenditures	-5.33M
Free Cash Flow	-26.92M
FCF Per Share	-$0.32

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DRTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.48%
Shareholder Yield	-4.48%
Earnings Yield	-11.50%
FCF Yield	-8.79%

Analyst Forecast

The average price target for DRTS is $9.00, which is 143.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	143.90%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1